These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29855474)

  • 21. Ceritinib increases sensitivity of AKT inhibitors to gastric cancer.
    Wang J; Xu X; Wang T; Guo Q; Dai X; Guo H; Zhang W; Cheng S; Chen X; Ding L
    Eur J Pharmacol; 2021 Apr; 896():173879. PubMed ID: 33515539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2
    Liu Z; Jiang L; Li Y; Xie B; Xie J; Wang Z; Zhou X; Jiang H; Fang Y; Pan H; Han W
    EBioMedicine; 2019 Apr; 42():326-339. PubMed ID: 30879923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway.
    Wang G; Lu M; Yao Y; Wang J; Li J
    Eur J Pharmacol; 2017 Nov; 814():207-215. PubMed ID: 28847482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crizotinib overcomes hepatocyte growth factor-mediated resistance to gefitinib in EGFR-mutant non-small-cell lung cancer cells.
    Chen X; Zhou JY; Zhao J; Chen JJ; Ma SN; Zhou JY
    Anticancer Drugs; 2013 Nov; 24(10):1039-46. PubMed ID: 23962905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.
    Sampson VB; Vetter NS; Kamara DF; Collier AB; Gresh RC; Kolb EA
    PLoS One; 2015; 10(11):e0142704. PubMed ID: 26571493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
    Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW
    Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells.
    Zhao H; Zhao D; Jin H; Li H; Yang X; Zhuang L; Liu T
    Mol Med Rep; 2016 Aug; 14(2):1817-22. PubMed ID: 27357249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4,5-Diphenyl-2-methyl picolinate induces cellular senescence by accumulating DNA damage and activating associated signaling pathways in gastric cancer.
    Zhao Z; Shang D; Qiu L; Guo C; Li Y; Liu H; Yuan G; Tu Z
    Life Sci; 2019 Dec; 238():116973. PubMed ID: 31639393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J
    PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
    Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Epstein-Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization.
    Wang J; Nagy N; Masucci MG
    Oncogene; 2020 Jan; 39(3):603-616. PubMed ID: 31511648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
    Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
    Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
    Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
    Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
    World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MTH1 Inhibitor TH287 Suppresses Gastric Cancer Development Through the Regulation of PI3K/AKT Signaling.
    Zhan D; Zhang X; Li J; Ding X; Cui Y; Jia J
    Cancer Biother Radiopharm; 2020 Apr; 35(3):223-232. PubMed ID: 32077746
    [No Abstract]   [Full Text] [Related]  

  • 39. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion.
    Sun ZL; Dong JL; Wu J
    Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
    Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
    Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.